Forest Laboratories Inc. said Wednesday shareholders have elected one of four candidates nominated by billionaire investor Carl Icahn to the drugmaker’s board of directors in a proxy contest.
Shareholders chose Icahn nominee Pierre Legault and nine candidates backed by the New York drugmaker, according to preliminary results.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.